Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Niketa C. Shah"'
Autor:
Maya Eylon, Snehit Prabhu, Samuel John, Maxwell J. M. King, Dhruv Bhatt, Kevin J. Curran, Courtney Erickson, Nicole A. Karras, Christine L. Phillips, Prakash Satwani, Michelle Hermiston, Erica Southworth, Susanne H. C. Baumeister, Julie-An Talano, Margaret L. MacMillan, Jenna Rossoff, Challice L. Bonifant, Gary Doug Myers, Rayne H. Rouce, Keri Toner, Timothy A. Driscoll, Emmanuel Katsanis, Dana B. Salzberg, Deborah Schiff, Satiro N. De Oliveira, Christian M. Capitini, Holly L. Pacenta, Thomas Pfeiffer, Niketa C. Shah, Van Huynh, Jodi L. Skiles, Ellen Fraint, Kevin O. McNerney, Troy C. Quigg, Joerg Krueger, John A. Ligon, Vanessa A. Fabrizio, Christina Baggott, Theodore W. Laetsch, Liora M. Schultz
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionMediport use as a clinical option for the administration of chimeric antigen receptor T cell (CAR T cell) therapy in patients with B-cell malignancies has yet to be standardized. Concern for mediport dislodgement, cell infiltration, and i
Externí odkaz:
https://doaj.org/article/63c1f7316ab94ecab4e03921e246dcfd
Autor:
Andromachi Scaradavou, Meghan A. Higman, Barbara Spitzer, Jennifer Allen, Nicholas D. Yeager, Audrey Mauguen, Nancy A. Kernan, Elliot Stieglitz, Maria Cancio, Farid Boulad, Niketa C. Shah, Kevin J Curran, Vanessa A Fabrizio, Susan E. Prockop, Steven P. Margossian, Richard J. O'Reilly, Renier J. Brentjens, Jaap Jan Boelens
Publikováno v:
Bone marrow transplantation, vol 55, iss 11
Bone marrow transplantation
Bone marrow transplantation
To define the tolerability and outcome of allogeneic hematopoietic stem cell transplant (allo-HSCT) following CAR T-cell therapy, we retrospectively reviewed pediatric/young adult patients with relapsed/refractory B-ALL who underwent this treatment.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32cde197e69454cd2acee0da2cb995dc
https://escholarship.org/uc/item/9sv0d1wj
https://escholarship.org/uc/item/9sv0d1wj